Hisamitsu Pharmaceutical Co Inc is categorized under Medical Research in Carlsbad, CA and active since 1998.
Hisamitsu Pharmaceutical Co Inc was established in 1998, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Nakatomi Hirotaka at the company’s headquarters by writing to 2730 Loker Avenue West, Carlsbad, California CA 92010 or by phoning (760) 431-4670. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hisamitsu Pharmaceutical Co Inc |
| Contact Person: | Nakatomi Hirotaka |
| Address: | 2730 Loker Avenue West, Carlsbad, California 92010 |
| Phone Number: | (760) 431-4670 |
| Website Address: | noven.com |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 1998 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Hisamitsu Pharmaceutical Co Inc was started in 1998 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Nakatomi Hirotaka for inquiries that concern Hisamitsu Pharmaceutical Co Inc by calling the company number (760) 431-4670, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Hisamitsu Pharmaceutical Co Inc can be found at the coordinates 33.133235,-117.259293 as well as the street address 2730 Loker Avenue West in Carlsbad, California 92010.
For its online presence, you may visit Hisamitsu Pharmaceutical Co Inc’s website at noven.com and engage with its social media outlets through on Twitter and on Facebook.